Search

Coronavirus US: Vaccine trial participant fainted after injection

CORONAVIRUS US: VACCINE TRIAL PARTICIPANT FAINTED AFTER INJECTION

Ian Haydon, 29, from Seattle, Washington, developed a 103.2F fever and fainted at home after receiving his second dose of Moderna Therapueticss'...

US pharmacies plan for surge in flu vaccines as two-thirds of Americans plan to get jab in the fall

US PHARMACIES PLAN FOR SURGE IN FLU VACCINES AS TWO-THIRDS OF AMERICANS PLAN TO GET JAB IN THE FALL

US pharmacies are preparing for a surge of customers asking for the flu vaccine as 60% of Americans said in a new poll that they either...

 
 
 
Merck joins the race to develop coronavirus vaccines and therapies

MERCK JOINS THE RACE TO DEVELOP CORONAVIRUS VACCINES AND THERAPIES

PHILADELPHIA - Merck, a global leader in vaccine development, is joining the frenzied rush to vanquish the coronavirus, announcing...

MERCK INKS THEMIS BUYOUT TO JOIN COVID-19 VACCINE RACE

Merck inks Themis buyout to join COVID-19 vaccine race ntaylor Tue, 05/26/2020 - 05:54

 
 
 
How the biotech upstart Moderna exploded into one of the most important startups of all time, leading the coronavirus vaccine race

HOW THE BIOTECH UPSTART MODERNA EXPLODED INTO ONE OF THE MOST IMPORTANT STARTUPS OF ALL TIME, LEADING THE CORONAVIRUS VACCINE RACE

Andrew Harnik/AP Images In its short corporate history, Moderna has grown accustomed to breaking records. A $450 million funding round...

Pharma giant Merck just jumped into the coronavirus race with 2 vaccine candidates slated to start human testing this year

PHARMA GIANT MERCK JUST JUMPED INTO THE CORONAVIRUS RACE WITH 2 VACCINE CANDIDATES SLATED TO START HUMAN TESTING THIS YEAR

Evan Agostini/Invision/AP One of the world's biggest drugmakers officially jumped into the race for coronavirus treatments and vaccines. The...

 
 
 
Global stocks march higher as coronavirus lockdowns ease and economic activity picks up

GLOBAL STOCKS MARCH HIGHER AS CORONAVIRUS LOCKDOWNS EASE AND ECONOMIC ACTIVITY PICKS UP

Global stocks rose on Tuesday as investor sentiment was propped up by a relaxation in coronavirus lockdowns across the world and on...

Human coronavirus vaccine trials to begin in Australia TODAY with 130 people

HUMAN CORONAVIRUS VACCINE TRIALS TO BEGIN IN AUSTRALIA TODAY WITH 130 PEOPLE

The testing will mark the first human trial of a COVID-19 vaccine in the Southern Hemisphere and will take place at Melbourne 's Alfred...

 
 
 
US biotech firm Novavax begins Covid-19 vaccine trials on Australian volunteers after getting $388mn from Bill Gates-backed fund

US BIOTECH FIRM NOVAVAX BEGINS COVID-19 VACCINE TRIALS ON AUSTRALIAN VOLUNTEERS AFTER GETTING $388MN FROM BILL GATES-BACKED FUND

Novavax is testing a new coronavirus vaccine on human subjects for the first time, launching a phase one clinical trial with a massive...

Witchcraft or Vaccines? Covid-19 vaccine will contain GMOs and “continuous” aborted human fetal cells, which develop into CANCER in your body

WITCHCRAFT OR VACCINES? COVID-19 VACCINE WILL CONTAIN GMOS AND “CONTINUOUS” ABORTED HUMAN FETAL CELLS, WHICH DEVELOP INTO CANCER IN YOUR BODY

Vaccine sorcery is underway folks, and you if don't learn how to read vaccine literature right now, you are in for a rude awakening....

 
 
 
Harvard scientists are developing a coronavirus vaccine specifically for those most vulnerable: the elderly

HARVARD SCIENTISTS ARE DEVELOPING A CORONAVIRUS VACCINE SPECIFICALLY FOR THOSE MOST VULNERABLE: THE ELDERLY

Various factors affect the effectiveness of a vaccine , including the age and sex of the person receiving it. Researchers at Boston...

Oxford scientists working on a coronavirus vaccine say there is now only a 50% chance of success because the number of UK cases is falling too quickly

OXFORD SCIENTISTS WORKING ON A CORONAVIRUS VACCINE SAY THERE IS NOW ONLY A 50% CHANCE OF SUCCESS BECAUSE THE NUMBER OF UK CASES IS FALLING TOO QUICKLY

Oxford scientists working on a coronavirus vaccine say the chances of success are now 50%. They say that's because the number of people...

 
 
 
More than 40% of Republicans think Bill Gates will use a COVID-19 vaccine to implant a location-tracking microchip in recipients, according to survey

MORE THAN 40% OF REPUBLICANS THINK BILL GATES WILL USE A COVID-19 VACCINE TO IMPLANT A LOCATION-TRACKING MICROCHIP IN RECIPIENTS, ACCORDING TO SURVEY

A new Yahoo News and YouGov surve y found that 44% of Republicans surveyed believe that Bill Gates will use the coronavirus vaccine...

Just over half of Americans would definitely get vaccinated against the coronavirus, a new survey found

JUST OVER HALF OF AMERICANS WOULD DEFINITELY GET VACCINATED AGAINST THE CORONAVIRUS, A NEW SURVEY FOUND

Only half of Americans say they would get vaccinated against the novel coronavirus, if and when a vaccine becomes available, according...

 
 
 
The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time

THE UNTOLD STORY OF MODERNA AS THE BIOTECH'S CORONAVIRUS VACCINE FACES A TEST THAT COULD MAKE IT ONE OF THE MOST CONSEQUENTIAL STARTUPS OF ALL TIME

The biotech Moderna has skyrocketed to global prominence, leading the world's race for a coronavirus vaccine. The Cambridge, Massachusetts-based...

 
 
 
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche's Protein Play & More

BIO ROUNDUP: MRNA VACCINE DATA, RISE OF RALLYBIO, ROCHE'S PROTEIN PLAY & MORE

As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials...

500 people in Wales set to take part in coronavirus vaccine trial

500 PEOPLE IN WALES SET TO TAKE PART IN CORONAVIRUS VACCINE TRIAL

The aim is to find a safe vaccine that will develop immunity against the virus and prevent the disease from spreading

 
 
 
China's coronavirus vaccine is 'safe' in world's first completed human trial

CHINA'S CORONAVIRUS VACCINE IS 'SAFE' IN WORLD'S FIRST COMPLETED HUMAN TRIAL

A Chinese study of 108 volunteers found that none of them had serious side effects from a coronavirus vaccine created there. It's a...

Moderna climbs 5% as Fauci calls its early COVID-19 vaccine data 'quite promising'

MODERNA CLIMBS 5% AS FAUCI CALLS ITS EARLY COVID-19 VACCINE DATA 'QUITE PROMISING'

Associated Press Dr. Anthony Fauci made a series of positive comments about Moderna 's early COVID-19 vaccine data on Thursday night...